Global Cord Blood Corporation
Symbol: CO
NYSE
2.9876
USDTržní cena dnes
5.2326
Poměr P/E
-0.0019
Poměr PEG
400.08M
MRK Cap
- 0.00%
Výnos DIV
Global Cord Blood Corporation (CO) finanční výkazy
Rozvaha
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 6661 | 6075.8 | 5473.4 | ||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.net-receivables | 0 | 161.3 | 130.3 | 104.3 | ||||||||||||||||
balance-sheet.row.inventory | 0 | 45.9 | 44.3 | 43.8 | ||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 11.9 | 47.8 | 44.8 | ||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 6935 | 6298.1 | 5666.2 | ||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 476.7 | 503.7 | 527.2 | ||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 83.6 | 88.2 | 92.8 | ||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 83.6 | 88.2 | 92.8 | ||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 282.3 | 307 | 290.4 | ||||||||||||||||
balance-sheet.row.tax-assets | 0 | 60.8 | 55.8 | 50.7 | ||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 696.2 | 653.4 | 592.5 | ||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 1599.5 | 1608.2 | 1553.7 | ||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-assets | 0 | 8534.5 | 7906.3 | 7219.9 | ||||||||||||||||
balance-sheet.row.account-payables | 0 | 8.3 | 9.5 | 20 | ||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 0.1 | 1.6 | 1.7 | ||||||||||||||||
balance-sheet.row.tax-payables | 0 | 31.2 | 29.5 | 32.3 | ||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 0 | 0.1 | 1.8 | ||||||||||||||||
Deferred Revenue Non Current | 0 | 2473.5 | 2392.9 | 2289.8 | ||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 179.8 | 166 | 146.3 | ||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 3003 | 2891.4 | 2760.6 | ||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0.1 | 1.8 | 3.5 | ||||||||||||||||
balance-sheet.row.total-liab | 0 | 3649.6 | 3517.9 | 3331.4 | ||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.common-stock | 0 | 0.1 | 0.1 | 0.1 | ||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 2887.3 | 2386.2 | 1877.9 | ||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | -106.8 | -103.2 | -94.7 | ||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 2098.8 | 2098.8 | 2098.8 | ||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 4879.3 | 4381.9 | 3882.1 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 8534.5 | 7906.3 | 7219.9 | ||||||||||||||||
balance-sheet.row.minority-interest | 0 | 5.7 | 6.6 | 6.4 | ||||||||||||||||
balance-sheet.row.total-equity | 0 | 4885 | 4388.5 | 3888.5 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||||||
Total Investments | 0 | 282.3 | 307 | 290.4 | ||||||||||||||||
balance-sheet.row.total-debt | 0 | 0.1 | 1.8 | 3.5 | ||||||||||||||||
balance-sheet.row.net-debt | 0 | -6660.8 | -6074 | -5469.9 |
Výkaz peněžních toků
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 509.5 | 516.2 | 477.7 | ||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 47.9 | 49.1 | 49.4 | ||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 3.2 | -7.2 | -7.2 | ||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 11.7 | 37.6 | ||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -3.8 | 58.3 | 64.1 | ||||||||||||||||
cash-flows.row.account-receivables | 0 | -102.9 | -120.4 | -86.9 | ||||||||||||||||
cash-flows.row.inventory | 0 | -5.3 | -6.8 | -24.1 | ||||||||||||||||
cash-flows.row.account-payables | 0 | -1.1 | -10.5 | -13.6 | ||||||||||||||||
cash-flows.row.other-working-capital | 0 | 105.7 | 196.1 | 188.6 | ||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 56.7 | 2.6 | 2.3 | ||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -19.8 | -20.9 | -24.2 | ||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | -340 | ||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 210 | ||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0.2 | 0.8 | 8.2 | ||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -19.6 | -20.1 | -146.1 | ||||||||||||||||
cash-flows.row.debt-repayment | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.other-financing-activites | 0 | -7.7 | -6.1 | -4 | ||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -7.7 | -6.1 | -4 | ||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | -1.1 | -2.1 | 1.6 | ||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 585.2 | 602.4 | 475.5 | ||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 6661 | 6075.8 | 5473.4 | ||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 6075.8 | 5473.4 | 4997.9 | ||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 613.6 | 630.7 | 624 | ||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -19.8 | -20.9 | -24.2 | ||||||||||||||||
cash-flows.row.free-cash-flow | 0 | 593.8 | 609.8 | 599.8 |
Řádek výkazu zisku a ztráty
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1243.3 | 1159.6 | 1221.5 | ||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 183.3 | 178.9 | 189.1 | ||||||||||||||||
income-statement-row.row.gross-profit | 0 | 1059.9 | 980.7 | 1032.3 | ||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-expenses | 0 | 6.3 | 8.2 | 7.4 | ||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 451.1 | 435.8 | 473.3 | ||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 634.4 | 614.8 | 662.4 | ||||||||||||||||
income-statement-row.row.interest-income | 0 | 32.6 | 30.9 | 25.4 | ||||||||||||||||
income-statement-row.row.interest-expense | 0 | -38.6 | 0 | 0 | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 19 | 65.9 | 19.8 | ||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 6.3 | 8.2 | 7.4 | ||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 19 | 65.9 | 19.8 | ||||||||||||||||
income-statement-row.row.interest-expense | 0 | -38.6 | 0 | 0 | ||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 19.9 | -26.8 | 13 | ||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.operating-income | 0 | 608.9 | 544.9 | 559 | ||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 627.8 | 610.8 | 578.8 | ||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 118.4 | 94.5 | 101.1 | ||||||||||||||||
income-statement-row.row.net-income | 0 | 501.1 | 508.2 | 470.7 |
Často kladené otázky
Co je Global Cord Blood Corporation (CO) celková aktiva?
Global Cord Blood Corporation (CO) celková aktiva jsou 8534525000.000.
Jaký je roční obrat podniku?
Roční příjmy jsou N/A.
Jaké je ziskové rozpětí podniku?
Zisková marže firmy je 0.853.
Jaký je volný peněžní tok podniku?
Volný peněžní tok je 4.885.
Jaká je čistá zisková marže podniku?
Čistá zisková marže je 0.403.
Jaké jsou celkové tržby podniku?
Celkové příjmy jsou 0.490.
Co je Global Cord Blood Corporation (CO) čistý zisk (čistý příjem)?
Čistý zisk (čistý příjem) je 501065000.000.
Jaký je celkový dluh podniku?
Celkový dluh je 147000.000.
Jaké je číslo provozních nákladů?
Provozní výdaje jsou 451083000.000.
Jaké je číslo peněžních prostředků firmy?
Peněžní prostředky podniku jsou 0.000.